Julie Neill - Trucept Director COO
| TREP Stock | USD 0.05 0.02 52.81% |
Insider
Julie Neill is Director COO of Trucept
| Phone | 858-923-4225 |
| Web | https://trucept.com |
Trucept Management Efficiency
Trucept's management efficiency ratios could be used to measure how well Trucept manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Anthony Goodman | Korn Ferry | N/A | |
| Valerie BeaulieuJames | Adecco Group | 56 | |
| Cheryl DCruzYoung | Korn Ferry | N/A | |
| Caroline Lomot | The Caldwell Partners | N/A | |
| James Bethmann | The Caldwell Partners | 69 | |
| Karen Fichuk | Randstad Holdings NV | 58 | |
| Mary Waddill | Adecco Group | N/A | |
| Peter Reed | The Caldwell Partners | N/A | |
| CPA CFA | The Caldwell Partners | N/A | |
| Jo Chapman | Hudson Global | N/A | |
| Vijay Konda | Korn Ferry | N/A | |
| Esther Colwill | Korn Ferry | N/A | |
| Rob MD | Randstad Holdings NV | N/A | |
| Rebecca Henderson | Randstad Holdings NV | 60 | |
| Wang Tammy | Korn Ferry | N/A | |
| Robert Sparno | Korn Ferry | N/A | |
| Andrea Walsh | Korn Ferry | N/A | |
| Greg Desnoyers | Korn Ferry | N/A | |
| Laura Bishop | Korn Ferry | 38 | |
| Pamela Cioffi | The Caldwell Partners | N/A | |
| Paula Nolan | Hudson Global | N/A | |
Management Performance
| Return On Equity | 0.0036 | |||
| Return On Asset | -0.006 |
Trucept Management Team
Elected by the shareholders, the Trucept's board of directors comprises two types of representatives: Trucept inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Trucept. The board's role is to monitor Trucept's management team and ensure that shareholders' interests are well served. Trucept's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Trucept's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Norman Esq, President, CEO | ||
| Julie Neill, Director COO | ||
| M Mowrey, Ex Division |
Trucept Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Trucept a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0036 | |||
| Return On Asset | -0.006 | |||
| Profit Margin | 0 % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 221.15 K | |||
| Shares Outstanding | 50.26 M | |||
| Price To Earning | (0.05) X | |||
| Price To Sales | 0.10 X | |||
| Revenue | 20 M | |||
| Gross Profit | 9.31 M |
Pair Trading with Trucept
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Trucept position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Trucept will appreciate offsetting losses from the drop in the long position's value.Moving against Trucept Pink Sheet
| 0.49 | SHG | Shinhan Financial | PairCorr |
| 0.47 | BCH | Banco De Chile | PairCorr |
| 0.42 | RANJF | Randstad NV | PairCorr |
| 0.37 | AHEXY | Adecco Group | PairCorr |
| 0.33 | WF | Woori Financial Group | PairCorr |
The ability to find closely correlated positions to Trucept could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Trucept when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Trucept - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Trucept to buy it.
The correlation of Trucept is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Trucept moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Trucept moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Trucept can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Trucept Pink Sheet Analysis
When running Trucept's price analysis, check to measure Trucept's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trucept is operating at the current time. Most of Trucept's value examination focuses on studying past and present price action to predict the probability of Trucept's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trucept's price. Additionally, you may evaluate how the addition of Trucept to your portfolios can decrease your overall portfolio volatility.